ASSOCIATION OF GENDER WITH STENT THROMBOSIS AND SHORT- TERM MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

被引:0
|
作者
Kumar, Aneel [1 ]
Kumar, Rajesh [2 ,4 ]
Mujtaba, Mustajab [2 ]
Ahmed, Rameez [2 ]
Rahooja, Kubbra [2 ]
Rasool, Ghulam [2 ]
Talpur, Mir Fahad Hussain [2 ]
Ali, Ahsan [2 ]
Basit, Abdul [2 ]
Samad, Maryam [2 ]
Yaqoob, Salma [2 ]
Siddiqui, Maria Noor [1 ]
Wadhwani, Anesh [3 ]
Kumar, Yogesh [3 ]
Raja, Rahul [3 ]
机构
[1] SMBZAN Inst Cardiol, Quetta, Pakistan
[2] Natl Inst Cardiovasc Dis, Karachi, Pakistan
[3] Dow Univ Hlth Sci, Karachi, Pakistan
[4] Natl Inst Cardiovasc Dis NICVD, Cardiol, Karachi, Pakistan
来源
PAKISTAN HEART JOURNAL | 2022年 / 55卷 / 03期
关键词
STEMI; primary PCI; stent thrombosis; MACE; gender; ELEVATION MYOCARDIAL-INFARCTION; DRUG-ELUTING STENTS; PREDICTORS; OUTCOMES; REVASCULARIZATION; MANAGEMENT; WOMEN; MEN;
D O I
10.47144/phj.v55i3.2306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Gender has been reported to be an independent predictor of stent thrombosis (ST), however, very limited data are available regarding gender disparities in the incidence of ST after primary percutaneous coronary intervention (PCI). Therefore, the objective of this study was to compare the incidence of ST among males and females after primary PCI.Methodology: In this study, we included consecutive patients diagnosed with ST-elevation myocardial infarction undergoing primary PCI. The incidence of ST and short-term major adverse cardiovascular events (MACE) were compared between male and female cohorts.Results: The gender distribution was 21% (368) female and 79% (1388) male patients. In the unmatched cohorts of females and males, the incidence of ST was 3.3% (12) vs. 5.3% (74); p=0.102, respectively. Short-term all-cause mortality rate was 12.2% (45) vs. 8.6% (119); p=0.032 among female and male patients, respectively. After propensity matching of the baseline characteristics, the incidence of stent thrombosis was 3.3% (12) vs. 4.9% (18); p=0.263 among females and male counterparts, respectively. The short-term all-cause mortality rate was 12.2% (45) vs. 10.6% (39); p=0.487 among female and propensity-matched male cohorts, respectively. Conclusion: There are no gender-based disparities in the incidence of ST as well as short-term MACE after primary PCI. The gender of the patient itself does not determine the prognosis of the patient, but longer ischemic time, older age, and consequently higher burden of risk factors confound the effect of the female gender.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 50 条
  • [1] Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Chen, Zhihao
    Jiang, Chaohui
    Qu, Huimin
    Liang, Shuang
    Yang, Jian
    Wu, Hui
    He, Chao
    Wang, Xinan
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1375 - 1380
  • [2] Gender is Not a Predictor of Mortality or Major Adverse Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes
    Josiah, Angeline
    Farshid, Ahmad
    HEART LUNG AND CIRCULATION, 2019, 28 (05): : 727 - 734
  • [3] Major adverse cardiovascular and cerebral events in hypothyroid patients undergoing percutaneous coronary intervention
    Pasqualetti, Giuseppe
    Calsolaro, Valeria
    Monzani, Fabio
    JOURNAL OF THORACIC DISEASE, 2016, 8 (06)
  • [4] Association between late sleeping and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Lian, Xiao-Qing
    Jiang, Kun
    Chen, Xiang-Xuan
    Dong, Hai-Cui
    Zhang, Yu-Qing
    Wang, Lian-Sheng
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [5] De Ritis ratio and long-term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention
    Ndrepepa, Gjin
    Holdenrieder, Stefan
    Kastrati, Adnan
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53 (05)
  • [6] Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
    Cai, Anping
    Dillon, Chrisly
    Hillegass, William B.
    Beasley, Mark
    Brott, Brigitta C.
    Bittner, Vera A.
    Perry, Gilbert J.
    Halade, Ganesh V.
    Prabhu, Sumanth D.
    Limdi, Nita A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [7] Short- and Long-Term Major Adverse Cardiac Events in Patients Undergoing Percutaneous Coronary Intervention with Stenting for Acute Myocardial Infarction Complicated by Cardiogenic Shock
    Marcolino, Milena Soriano
    Simsek, Cihan
    de Boer, Sanneke P. M.
    van Domburg, Ron T.
    van Geuns, Robert-Jan
    de Jaegere, Peter
    Akkerhuis, K. Martijn
    Daemen, Joost
    Serruys, Patrick W.
    Boersma, Eric
    CARDIOLOGY, 2012, 121 (01) : 47 - 55
  • [8] Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Xiao, Zhibin
    Riletu, Aoge
    Yan, Xiaoyu
    Meng, Qi
    Zhang, Weiru
    Zhang, Na
    Ma, Chi
    Guo, Xin
    Han, Jiatong
    Nie, Huijuan
    Deng, Hui
    Liu, Jing
    Chen, Jianping
    Dong, Yu
    Liu, Tianlong
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (04) : 621 - 629
  • [9] Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Turgeon, Ricky D.
    Koshman, Sheri L.
    Youngson, Erik
    Har, Bryan
    Wilton, Stephen B.
    James, Matthew T.
    Graham, Michelle M.
    JAMA INTERNAL MEDICINE, 2020, 180 (03) : 420 - 428
  • [10] Association of admission anemia and renal failure on short- and long-term outcomes in patients undergoing primary percutaneous coronary intervention
    Zaharijev, S.
    Milasinovic, D.
    Dobras, J.
    Mehmedbegovic, Z.
    Pavlovic, A.
    Zivkovic, I.
    Radomirovic, M.
    Stevanovic, M.
    Stankovic, S.
    Asanin, M.
    Vukcevic, V.
    Stankovic, G.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1200 - 1201